Kewaunee Scientific Corporation (KEQU) to Acquire Nycom for $55M Base Price
閱讀少於1分鐘
Kewaunee Scientific agreed to acquire Nycom for an initial base price of $55M, subject to EBITDA and customary post-closing adjustments. The deal is expected to close in Q4 fiscal 2027, subject to customary conditions.
Material Details
| # | Detail | AI Analyst View |
|---|---|---|
| 1 | $55M initial base purchase price | Establishes the deal's initial valuation; the final price can rise or fall based on EBITDA and customary closing adjustments. |
| 2 | $20M payable in subordinated note | Defers part of the consideration, with the note amount subject to EBITDA adjustments. |
| 3 | $5M payable in newly issued shares | Creates equity dilution for existing shareholders; the release gives no share count. |
| 4 | Expected to close in Q4 fiscal 2027 | The deal remains subject to customary closing conditions, so completion is not assured. |
| 5 | Nycom founder to join Kewaunee's board | Adds the seller's founder to the board at closing, linking Nycom leadership to post-deal oversight. |
Context by AI Analyst
This is a strategic expansion of Kewaunee's laboratory business through ownership of a long-standing distribution and installation partner. Closing the transaction and subsequent disclosures on final consideration, financing, and integration would determine whether it becomes a larger catalyst.
Based on the original press release from Kewaunee Scientific Corporation distributed by PR Newswire.
This is an AI-generated summary and may contain inaccuracies. Summary is based on content distributed by PR Newswire. Please verify any important information with the original source. This information is not a recommendation for what you should do personally and does not constitute investment advice.
© Copyright 2026 Cision US Inc. All Rights Reserved.